KITLG adenovirus

KITLG, also known as Stem Cell Factor (SCF), Steel factor, or Mast Cell Growth Factor, encodes a crucial cytokine that is the ligand for the receptor tyrosine kinase KIT (CD117). KITLG exists in both membrane-bound and soluble forms, generated by alternative splicing and proteolytic shedding, enabling diverse paracrine and juxtacrine signaling. Upon binding, KIT dimerizes and activates multiple downstream pathways, including the PI3K–AKT, RAS–MAPK, and JAK–STAT pathways, promoting the survival, proliferation, differentiation, adhesion, and migration of various cell types. Biologically, KITLG is essential for hematopoiesis (supporting hematopoietic stem and progenitor cells), melanocyte development and pigmentation, germ cell maintenance and fertility, and mast cell development and function. It is primarily expressed by stromal and microenvironmental cells in the bone marrow and other tissues, where it orchestrates microenvironmental signaling to KIT-positive target cells. Congenital defects in the KIT or KITLG pathway underlie pigmentary disorders (e.g., vitiligo) and reproductive problems, while aberrant KIT activity contributes to various tumors (e.g., gastrointestinal stromal tumors and mastocytosis, often through KIT mutations rather than ligand overexpression).

The KITLG adenovirus is a replication-deficient human adenovirus type 5 (dE1/E3) vector engineered to express the KIT ligand with a C-terminal V5 epitope tag under the control of a CMV promoter. This construct allows for high-level transient expression in various mammalian cells, facilitating precise control of KIT pathway activation in vitro and in vivo. It is ideally suited for gain-of-function studies: researchers can restore KITLG activity in deficient systems, map dose-response relationships, and dissect downstream signaling dynamics using phosphoproteomics or reporter gene assays. Because KITLG acts on KIT-positive cells such as hematopoietic progenitors, melanocytes, germ cells, and mast cells, this vector supports co-culture experiments to study the effects of paracrine signaling on cell survival, proliferation, chemotaxis, and microenvironmental interactions. In the field of translational medicine, it can be used to simulate the supportive role of the tumor microenvironment on malignant tumors expressing KIT (such as certain acute myeloid leukemias, mast cell tumors, or gastrointestinal stromal tumor models) and to evaluate autocrine or paracrine signaling loops.